Welcome to Sponge Shares
Welcome to the research area. Here you will find a number of research notes I have produced on a variety of companies I have invested in.
I only produce research notes on companies that I myself would invest in having done my own due-diligence and research. Most of these stocks fall into the mid-term, higher risk, high growth stocks category I mention in my strategy and are stocks I hope to see the biggest gains from.
Please remember these notes are my own opinion and do not constitute investment advice.
Contango Holdings PLC
Contango own 70% of the LUBU coking coal project in Zimbabwe. The project start-up is fully funded with the aim to commence production Q4 2020
The company offer near-term, significant cash flow generation with the aim to implement an early dividend policy with remaining cash for expansion or re-investment
Goldstone is in my opinion a hidden gem! They have two gold projects in close proximity in Ghana and on strike of one of the worlds largest producing gold mines.
Homase is the starter phase 1 project that sports an initial 144% IRR but has significant development and exploration upside potential.
Akrokeri, also a previously producing mine offers similar potential but with exceptionally high grades.
Fusion Antibodies Part 2
Fusion Antibodies offers a complete range of antibody-related services in discovery, engineering and supply and have guided hundreds of projects through critical preclinical stages.
In Part 2 I focus on the Mammalian antibody library and the work they are doing in the COVID-19 space. Validating the MAL would be a game-changer for the company.
Horizonte Minerals is the leading Nickel developer listed on the AIM market. They are currently developing two tier 1 nickel projects based in Brazil.
Ive been invested in Horizonte for a few years now and I believe today the investment opportunity is the best it has ever been.
In this research note I cover Armadale Capital, emerging Graphite producer in Tanzania. The company are developing a low cost, low capex, high purity and high grade graphite project with robust economics
East Africa is expected to be a critical source of natural flake graphite going forwards as the EV boom kicks in along with the demand for EV battery materials.
Fusion Antibodies Part 1
In this brief research note, I’m going to focus on Fusion Antibodies given it has a current market cap of £25m at time of writing largely under-pinned by its core business.
The company has recently executed a fundraise primarily to advance the Mammalian Antibody Library and to validate the library for commercialisation.